Skip to content
Paysign logo

Paysign

PAYS

Paysign is a vertically integrated provider of prepaid card products and end-to-end payment processing services for corporate, consumer, and government entities.

Market cap
$490.85M+15.9%
Revenue$91.5M+43.4%
Net income$10.4M+70.8%
Free cash flow$75.9M+107%
EPS (diluted)$0.18+50.0%
Trailing twelve months · change vs. prior year

Earnings

Next report

Aug 4, 2026 (In 3 weeks)
Revenue estimate$26.3M
EPS estimate$0.06

Financials

Q1 2026

Income statement

See full
Revenue$28.0M+50.8%
Gross profit$18.2M+55.8%
Operating income$6.7M+168%
Net income$5.4M+110%
EPS (diluted)$0.09+80.0%

Balance sheet

See full
Cash & equivalents$20.5M+200%
Total debt$12.1M-4.6%
Total equity$55.0M+40.1%
Total assets$312.7M+52.5%

Cash flow

See full
Operating cash flow$18.8M+411%
CapEx$266.5K+239%
Free cash flow$18.5M+403%

Valuation & ratios

Valuation

See full
Market cap$490.85M+15.9%
Enterprise value$482.37M+8.0%
P/E47.2×-18.8×
P/S5.4×-1.2×

Profitability

See full
Gross margin60.4%+2.5pp
Operating margin12.6%+6.7pp
Net margin11.4%+1.8pp
FCF margin82.9%

Returns & leverage

See full
Return on equity22.1%+3.2pp
Debt / equity0.2×-0.1×
Current ratio1.1×0.0×

Segments

By product

See full
Pharma Industry$15.7M+81.9%
Plasma Industry$11.7M+24.9%
Other Revenue$610.4K+7.2%

Competitors

Profile

Paysign is a vertically integrated provider of prepaid card products and end-to-end payment processing services for corporate, consumer, and government entities. The company operates a high-availability fintech platform that manages the entire card lifecycle, including enrollment, transaction processing, and data analytics. Its core value proposition focuses on reducing administrative costs and increasing customer loyalty through customized payment solutions.

Competitive position

Paysign is a leading provider in the niche plasma donation compensation market and a specialized player in pharmaceutical co-pay assistance, leveraging a vertically integrated processing platform.

GeographiesUnited States, Puerto Rico
Customer segmentsPharmaceutical Companies, Healthcare Organizations, Corporate Enterprises, Unbanked/Underbanked Consumers
Business modelB2B2C, Transaction-based, SaaS, Licensing
SuppliersBank issuers, Payment networks (Visa, Mastercard, Discover), Data center providers, Card manufacturers
CustomersCorporate incentive program managers, Clinical trial sponsors, Retail pharmacies, Plasma donors, General consumers
Listed1998
Employees123.0
CEOMark Newcomer
FilingsSEC EDGAR

Questions, answered.

What is Paysign's market cap?
Paysign (PAYS) has a market capitalization of $490.9M and trades on NASDAQ.
What is Paysign's revenue and profitability?
Paysign generated $91.5M in trailing twelve-month revenue with net income of $10.4M, representing a net margin of 11.4%. Gross margin stands at 60.4%, with free cash flow of $75.9M. These figures are based on the Q1 2026 filing.
Who are Paysign's competitors?
Paysign's key competitors include Green Dot, Haemonetics Corporation, Repay Holdings Corporation Class A Common Stock, and others. These companies compete in similar markets and product categories.
Who does Paysign partner with?
Paysign's notable partners include Visa, Mastercard, Discover.
Where is Paysign headquartered?
Paysign is headquartered in United States of America and employs approximately 123 people. It has been publicly traded since 1998.